FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

10625311000001101: Lopinavir 200mg / Ritonavir 50mg tablets 120 tablet (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Oct 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
36252601000001114 Lopinavir 200mg / Ritonavir 50mg tablets 120 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
36252701000001116 Lopinavir 200mg / Ritonavir 50mg tablets 120 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


5 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lopinavir 200mg / Ritonavir 50mg tablets 120 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Lopinavir 200mg / Ritonavir 50mg tablets 120 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Lopinavir 200mg / Ritonavir 50mg tablets 120 tablet Is pack of Product containing precisely lopinavir 200 milligram and ritonavir 50 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Lopinavir 200mg / Ritonavir 50mg tablets 120 tablet Has active ingredient Ritonavir false Inferred relationship Existential restriction modifier
Lopinavir 200mg / Ritonavir 50mg tablets 120 tablet Has active ingredient Lopinavir false Inferred relationship Existential restriction modifier
Lopinavir 200mg / Ritonavir 50mg tablets 120 tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Lopinavir 200mg / Ritonavir 50mg tablets 120 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Lopinavir 200mg / Ritonavir 50mg tablets 120 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Lopinavir 200mg / Ritonavir 50mg tablets 120 tablet Has VMP Product containing precisely lopinavir 200 milligram and ritonavir 50 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Lopinavir 200mg / Ritonavir 50mg tablets 120 tablet Has specific active ingredient Ritonavir true Inferred relationship Existential restriction modifier
Lopinavir 200mg / Ritonavir 50mg tablets 120 tablet Has specific active ingredient Lopinavir true Inferred relationship Existential restriction modifier
Lopinavir 200mg / Ritonavir 50mg tablets 120 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Kaletra 200mg/50mg tablets (AbbVie Ltd) 120 tablet Is a True Lopinavir 200mg / Ritonavir 50mg tablets 120 tablet Inferred relationship Existential restriction modifier
Lopinavir 200mg / Ritonavir 50mg tablets (Accord Healthcare Ltd) 120 tablet 12 x 10 tablets Is a True Lopinavir 200mg / Ritonavir 50mg tablets 120 tablet Inferred relationship Existential restriction modifier
Lopinavir 200mg / Ritonavir 50mg tablets (Viatris UK Healthcare Ltd) 120 tablet 4 x 30 tablets Is a True Lopinavir 200mg / Ritonavir 50mg tablets 120 tablet Inferred relationship Existential restriction modifier
Lopinavir 200mg / Ritonavir 50mg tablets (A A H Pharmaceuticals Ltd) 120 tablet 12 x 10 tablets Is a True Lopinavir 200mg / Ritonavir 50mg tablets 120 tablet Inferred relationship Existential restriction modifier
Kaletra 200mg/50mg tablets (Abbott Laboratories Ltd) 120 tablet Is a True Lopinavir 200mg / Ritonavir 50mg tablets 120 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start